Skip to main content
Top
Published in: Pediatric Nephrology 12/2014

Open Access 01-12-2014 | Review

Biology of sepsis: Its relevance to pediatric nephrology

Authors: Neal B. Blatt, Sushant Srinivasan, Theresa Mottes, Maureen M. Shanley, Thomas P. Shanley

Published in: Pediatric Nephrology | Issue 12/2014

Login to get access

Abstract

Because of its multi-organ involvement, the syndrome of sepsis provides clinical challenges to a wide variety of health care providers. While multi-organ dysfunction triggered by sepsis requires general supportive critical care provided by intensivists, the impact of sepsis on renal function and the ability of renal replacement therapies to modulate its biologic consequences provide a significant opportunity for pediatric nephrologists and related care providers to impact outcomes. In this review, we aim to highlight newer areas of understanding of the pathobiology of sepsis with special emphasis on those aspects of particular interest to pediatric nephrology. As such, we aim to: (1) review the definition of sepsis and discuss advances in our mechanistic understanding of sepsis; (2) review current hypotheses regarding sepsis-induced acute kidney injury (AKI) and describe its epidemiology based on evolving definitions of AKI; (3) review the impact of renal failure on the immune system, highlighting the sepsis risk in this cohort and strategies that might minimize this risk; (4) review how renal replacement therapeutic strategies may impact sepsis-induced AKI outcomes. By focusing the review on these specific areas, we have omitted other important areas of the biology of sepsis and additional interactions with renal function from this discussion; however, we have aimed to provide a comprehensive list of references that provide contemporary reviews of these additional areas.
Literature
1.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedCrossRef Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedCrossRef
2.
go back to reference Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2–8PubMedCrossRef Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2–8PubMedCrossRef
3.
go back to reference Marshall JC (2000) Clinical trials of mediator-directed therapy in sepsis: what have we learned? Intensive Care Med 26(Suppl 1):S75–S83PubMedCrossRef Marshall JC (2000) Clinical trials of mediator-directed therapy in sepsis: what have we learned? Intensive Care Med 26(Suppl 1):S75–S83PubMedCrossRef
4.
go back to reference Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A (2009) Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 37:666–688PubMedCrossRef Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A (2009) Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 37:666–688PubMedCrossRef
5.
6.
go back to reference Carcillo JA, Pollack MM, Ruttimann UE, Fields AI (1989) Sequential physiologic interactions in pediatric cardiogenic and septic shock. Crit Care Med 17:12–16PubMedCrossRef Carcillo JA, Pollack MM, Ruttimann UE, Fields AI (1989) Sequential physiologic interactions in pediatric cardiogenic and septic shock. Crit Care Med 17:12–16PubMedCrossRef
7.
go back to reference Ceneviva G, Paschall JA, Maffei F, Carcillo JA (1998) Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 102:e19PubMedCrossRef Ceneviva G, Paschall JA, Maffei F, Carcillo JA (1998) Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 102:e19PubMedCrossRef
8.
go back to reference Medzhitov R, Janeway C Jr (2000) The Toll receptor family and microbial recognition. Trends Microbiol 8:452–456PubMedCrossRef Medzhitov R, Janeway C Jr (2000) The Toll receptor family and microbial recognition. Trends Microbiol 8:452–456PubMedCrossRef
10.
go back to reference Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, Horwood N, Nanchahal J (2012) Alarmins: awaiting a clinical response. J Clin Invest 122:2711–2719PubMedCrossRefPubMedCentral Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, Horwood N, Nanchahal J (2012) Alarmins: awaiting a clinical response. J Clin Invest 122:2711–2719PubMedCrossRefPubMedCentral
11.
go back to reference Denk S, Perl M, Huber-Lang M (2012) Damage- and pathogen-associated molecular patterns and alarmins: keys to sepsis? Eur Surg Res 48:171–179PubMedCrossRef Denk S, Perl M, Huber-Lang M (2012) Damage- and pathogen-associated molecular patterns and alarmins: keys to sepsis? Eur Surg Res 48:171–179PubMedCrossRef
12.
go back to reference Cerami A, Beutler B (1988) The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today 9:28–31PubMedCrossRef Cerami A, Beutler B (1988) The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today 9:28–31PubMedCrossRef
15.
go back to reference Cornell TT, Wynn J, Shanley TP, Wheeler DS, Wong HR (2010) Mechanisms and regulation of the gene-expression response to sepsis. Pediatrics 125:1248–1258PubMedCrossRefPubMedCentral Cornell TT, Wynn J, Shanley TP, Wheeler DS, Wong HR (2010) Mechanisms and regulation of the gene-expression response to sepsis. Pediatrics 125:1248–1258PubMedCrossRefPubMedCentral
16.
go back to reference Oberholzer A, Oberholzer C, Moldawer LL (2002) Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 30:S58–S63CrossRef Oberholzer A, Oberholzer C, Moldawer LL (2002) Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 30:S58–S63CrossRef
17.
go back to reference Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13:260–268PubMedCrossRefPubMedCentral Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13:260–268PubMedCrossRefPubMedCentral
18.
go back to reference Wong HR, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Willson DF, Freishtat RJ, Anas N, Meyer K, Checchia PA, Monaco M, Odom K, Shanley TP (2009) Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med 7:34PubMedCrossRefPubMedCentral Wong HR, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Willson DF, Freishtat RJ, Anas N, Meyer K, Checchia PA, Monaco M, Odom K, Shanley TP (2009) Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med 7:34PubMedCrossRefPubMedCentral
19.
go back to reference Hall MW, Knatz NL, Vetterly C, Tomarello S, Wewers MD, Volk HD, Carcillo JA (2011) Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med 37:525–532PubMedCrossRef Hall MW, Knatz NL, Vetterly C, Tomarello S, Wewers MD, Volk HD, Carcillo JA (2011) Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med 37:525–532PubMedCrossRef
20.
go back to reference Hotchkiss RS, Nicholson DW (2006) Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 6:813–822PubMedCrossRef Hotchkiss RS, Nicholson DW (2006) Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 6:813–822PubMedCrossRef
21.
go back to reference Torgersen C, Moser P, Luckner G, Mayr V, Jochberger S, Hasibeder WR, Dunser MW (2009) Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg 108:1841–1847PubMedCrossRef Torgersen C, Moser P, Luckner G, Mayr V, Jochberger S, Hasibeder WR, Dunser MW (2009) Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg 108:1841–1847PubMedCrossRef
22.
go back to reference Venet F, Lukaszewicz A-C, Payen D, Hotchkiss R, Monneret G (2013) Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol 25:477–483PubMedCrossRefPubMedCentral Venet F, Lukaszewicz A-C, Payen D, Hotchkiss R, Monneret G (2013) Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol 25:477–483PubMedCrossRefPubMedCentral
23.
go back to reference Mayeux PR, MacMillan-Crow LA (2012) Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury. Pharmacol Ther 134:139–155PubMedCrossRefPubMedCentral Mayeux PR, MacMillan-Crow LA (2012) Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury. Pharmacol Ther 134:139–155PubMedCrossRefPubMedCentral
24.
go back to reference Venkatachalam MA, Weinberg JM (2012) The tubule pathology of septic acute kidney injury: a neglected area of research comes of age. Kidney Int 81:338–340PubMedCrossRefPubMedCentral Venkatachalam MA, Weinberg JM (2012) The tubule pathology of septic acute kidney injury: a neglected area of research comes of age. Kidney Int 81:338–340PubMedCrossRefPubMedCentral
25.
go back to reference Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL (2004) Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 32:1825–1831PubMedCrossRef Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL (2004) Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 32:1825–1831PubMedCrossRef
27.
go back to reference De Backer D, Donadello K, Sakr Y, Ospina-Tascon G, Salgado D, Scolletta S, Vincent JL (2013) Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome. Crit Care Med 41:791–799PubMedCrossRef De Backer D, Donadello K, Sakr Y, Ospina-Tascon G, Salgado D, Scolletta S, Vincent JL (2013) Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome. Crit Care Med 41:791–799PubMedCrossRef
28.
go back to reference Cunningham PN, Wang Y, Guo R, He G, Quigg RJ (2004) Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 172:2629–2635PubMedCrossRef Cunningham PN, Wang Y, Guo R, He G, Quigg RJ (2004) Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 172:2629–2635PubMedCrossRef
29.
go back to reference Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ (2002) Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 168:5817–5823PubMedCrossRef Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ (2002) Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 168:5817–5823PubMedCrossRef
30.
go back to reference Pathak E, MacMillan-Crow LA, Mayeux PR (2012) Role of mitochondrial oxidants in an in vitro model of sepsis-induced renal injury. J Pharmacol Exp Ther 340:192–201PubMedCrossRefPubMedCentral Pathak E, MacMillan-Crow LA, Mayeux PR (2012) Role of mitochondrial oxidants in an in vitro model of sepsis-induced renal injury. J Pharmacol Exp Ther 340:192–201PubMedCrossRefPubMedCentral
31.
go back to reference Lee SY, Lee YS, Choi HM, Ko YS, Lee HY, Jo SK, Cho WY, Kim HK (2012) Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med 40:2997–3006PubMedCrossRef Lee SY, Lee YS, Choi HM, Ko YS, Lee HY, Jo SK, Cho WY, Kim HK (2012) Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med 40:2997–3006PubMedCrossRef
32.
go back to reference Wang Z, Holthoff JH, Seely KA, Pathak E, Spencer HJ 3rd, Gokden N, Mayeux PR (2012) Development of oxidative stress in the peritubular capillary microenvironment mediates sepsis-induced renal microcirculatory failure and acute kidney injury. Am J Pathol 180:505–516PubMedCrossRefPubMedCentral Wang Z, Holthoff JH, Seely KA, Pathak E, Spencer HJ 3rd, Gokden N, Mayeux PR (2012) Development of oxidative stress in the peritubular capillary microenvironment mediates sepsis-induced renal microcirculatory failure and acute kidney injury. Am J Pathol 180:505–516PubMedCrossRefPubMedCentral
33.
go back to reference Holthoff JH, Wang Z, Seely KA, Gokden N, Mayeux PR (2012) Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury. Kidney Int 81:370–378PubMedCrossRefPubMedCentral Holthoff JH, Wang Z, Seely KA, Gokden N, Mayeux PR (2012) Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury. Kidney Int 81:370–378PubMedCrossRefPubMedCentral
34.
go back to reference Wu L, Tiwari MM, Messer KJ, Holthoff JH, Gokden N, Brock RW, Mayeux PR (2007) Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am J Physiol Renal Physiol 292:F261–F268PubMedCrossRef Wu L, Tiwari MM, Messer KJ, Holthoff JH, Gokden N, Brock RW, Mayeux PR (2007) Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am J Physiol Renal Physiol 292:F261–F268PubMedCrossRef
35.
go back to reference Benes J, Chvojka J, Sykora R, Radej J, Krouzecky A, Novak I, Matejovic M (2011) Searching for mechanisms that matter in early septic acute kidney injury: an experimental study. Crit Care 15:R256PubMedCrossRefPubMedCentral Benes J, Chvojka J, Sykora R, Radej J, Krouzecky A, Novak I, Matejovic M (2011) Searching for mechanisms that matter in early septic acute kidney injury: an experimental study. Crit Care 15:R256PubMedCrossRefPubMedCentral
36.
go back to reference Langenberg C, Wan L, Egi M, May CN, Bellomo R (2006) Renal blood flow in experimental septic acute renal failure. Kidney Int 69:1996–2002PubMedCrossRef Langenberg C, Wan L, Egi M, May CN, Bellomo R (2006) Renal blood flow in experimental septic acute renal failure. Kidney Int 69:1996–2002PubMedCrossRef
37.
go back to reference Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, van’t Veer C (2002) In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168:1286–1293PubMedCrossRef Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, van’t Veer C (2002) In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168:1286–1293PubMedCrossRef
38.
go back to reference Goncalves GM, Zamboni DS, Camara NO (2010) The role of innate immunity in septic acute kidney injuries. Shock 34(Suppl 1):22–26PubMedCrossRef Goncalves GM, Zamboni DS, Camara NO (2010) The role of innate immunity in septic acute kidney injuries. Shock 34(Suppl 1):22–26PubMedCrossRef
39.
go back to reference Bonegio R, Lieberthal W (2002) Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11:301–308PubMedCrossRef Bonegio R, Lieberthal W (2002) Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11:301–308PubMedCrossRef
40.
go back to reference Jo SK, Cha DR, Cho WY, Kim HK, Chang KH, Yun SY, Won NH (2002) Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells. Nephron 91:406–415PubMedCrossRef Jo SK, Cha DR, Cho WY, Kim HK, Chang KH, Yun SY, Won NH (2002) Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells. Nephron 91:406–415PubMedCrossRef
41.
go back to reference Gando S (2010) Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 38:S35–S42PubMedCrossRef Gando S (2010) Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 38:S35–S42PubMedCrossRef
42.
go back to reference Hook KM, Abrams CS (2012) The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients. Clin Transl Sci 5:85–92PubMedCrossRef Hook KM, Abrams CS (2012) The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients. Clin Transl Sci 5:85–92PubMedCrossRef
43.
go back to reference Nguyen TC, Carcillo JA (2006) Bench-to-bedside review: thrombocytopenia-associated multiple organ failure–a newly appreciated syndrome in the critically ill. Crit Care 10:235PubMedCrossRefPubMedCentral Nguyen TC, Carcillo JA (2006) Bench-to-bedside review: thrombocytopenia-associated multiple organ failure–a newly appreciated syndrome in the critically ill. Crit Care 10:235PubMedCrossRefPubMedCentral
44.
go back to reference Nguyen T, Hall M, Han Y, Fiedor M, Hasset A, Lopez-Plaza I, Watson S, Lum L, Carcillo JA (2001) Microvascular thrombosis in pediatric multiple organ failure: Is it a therapeutic target? Pediatr Crit Care Med 2:187–196PubMedCrossRef Nguyen T, Hall M, Han Y, Fiedor M, Hasset A, Lopez-Plaza I, Watson S, Lum L, Carcillo JA (2001) Microvascular thrombosis in pediatric multiple organ failure: Is it a therapeutic target? Pediatr Crit Care Med 2:187–196PubMedCrossRef
45.
go back to reference Claus RA, Bockmeyer CL, Sossdorf M, Losche W (2010) The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure? Curr Mol Med 10:236–248PubMedCrossRef Claus RA, Bockmeyer CL, Sossdorf M, Losche W (2010) The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure? Curr Mol Med 10:236–248PubMedCrossRef
46.
go back to reference Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup (2004) Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212PubMedCrossRefPubMedCentral Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup (2004) Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212PubMedCrossRefPubMedCentral
47.
go back to reference Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL (2007) Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71:1028–1035PubMedCrossRef Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL (2007) Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71:1028–1035PubMedCrossRef
48.
go back to reference Mehta R, Kellum J, Shah S, Molitoris B, Ronco C, Warnock D, Levin A (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31PubMedCrossRefPubMedCentral Mehta R, Kellum J, Shah S, Molitoris B, Ronco C, Warnock D, Levin A (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31PubMedCrossRefPubMedCentral
49.
go back to reference KDIGO (2012) Clinical practice guideline for acute kidney injury. Section 2: AKI definition. Kidney Int Suppl 2:19–36CrossRef KDIGO (2012) Clinical practice guideline for acute kidney injury. Section 2: AKI definition. Kidney Int Suppl 2:19–36CrossRef
50.
go back to reference Vachvanichsanong P, Dissaneewate P, Lim A, McNeil E (2006) Childhood acute renal failure: 22-year experience in a university hospital in southern Thailand. Pediatrics 118:e786–e791PubMedCrossRef Vachvanichsanong P, Dissaneewate P, Lim A, McNeil E (2006) Childhood acute renal failure: 22-year experience in a university hospital in southern Thailand. Pediatrics 118:e786–e791PubMedCrossRef
51.
go back to reference Pundziene B, Dobiliene D, Rudaitis S (2010) Acute kidney injury in pediatric patients: experience of a single center during an 11-year period. Medicina (Kaunas) 46:511–515 Pundziene B, Dobiliene D, Rudaitis S (2010) Acute kidney injury in pediatric patients: experience of a single center during an 11-year period. Medicina (Kaunas) 46:511–515
52.
go back to reference Plotz FB, Hulst HE, Twisk JW, Bokenkamp A, Markhorst DG, van Wijk JA (2005) Effect of acute renal failure on outcome in children with severe septic shock. Pediatr Nephrol 20:1177–1181PubMedCrossRef Plotz FB, Hulst HE, Twisk JW, Bokenkamp A, Markhorst DG, van Wijk JA (2005) Effect of acute renal failure on outcome in children with severe septic shock. Pediatr Nephrol 20:1177–1181PubMedCrossRef
53.
go back to reference Ghani AA, Al Helal B, Hussain N (2009) Acute renal failure in pediatric patients: etiology and predictors of outcome. Saudi J Kidney Dis Transpl 20:69–76PubMed Ghani AA, Al Helal B, Hussain N (2009) Acute renal failure in pediatric patients: etiology and predictors of outcome. Saudi J Kidney Dis Transpl 20:69–76PubMed
54.
go back to reference Hui-Stickle S, Brewer ED, Goldstein SL (2005) Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45:96–101PubMedCrossRef Hui-Stickle S, Brewer ED, Goldstein SL (2005) Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45:96–101PubMedCrossRef
55.
go back to reference Miller ME, Williams JA (2002) Chronic renal failure in Jamaican children. West Indian Med J 51:220–224PubMed Miller ME, Williams JA (2002) Chronic renal failure in Jamaican children. West Indian Med J 51:220–224PubMed
56.
go back to reference Bailey D, Phan V, Litalien C, Ducruet T, Merouani A, Lacroix J, Gauvin F (2007) Risk factors of acute renal failure in critically ill children: a prospective descriptive epidemiological study. Pediatr Crit Care Med 8:29–35PubMedCrossRef Bailey D, Phan V, Litalien C, Ducruet T, Merouani A, Lacroix J, Gauvin F (2007) Risk factors of acute renal failure in critically ill children: a prospective descriptive epidemiological study. Pediatr Crit Care Med 8:29–35PubMedCrossRef
57.
go back to reference Plotz FB, Bouma AB, van Wijk JA, Kneyber MC, Bokenkamp A (2008) Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria. Intensive Care Med 34:1713–1717PubMedCrossRef Plotz FB, Bouma AB, van Wijk JA, Kneyber MC, Bokenkamp A (2008) Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria. Intensive Care Med 34:1713–1717PubMedCrossRef
58.
go back to reference Palmieri T, Lavrentieva A, Greenhalgh D (2009) An assessment of acute kidney injury with modified RIFLE criteria in pediatric patients with severe burns. Intensive Care Med 35:2125–2129PubMedCrossRefPubMedCentral Palmieri T, Lavrentieva A, Greenhalgh D (2009) An assessment of acute kidney injury with modified RIFLE criteria in pediatric patients with severe burns. Intensive Care Med 35:2125–2129PubMedCrossRefPubMedCentral
59.
go back to reference Duzova A, Bakkaloglu A, Kalyoncu M, Poyrazoglu H, Delibas A, Ozkaya O, Peru H, Alpay H, Soylemezoglu O, Gur-Guven A, Bak M, Bircan Z, Cengiz N, Akil I, Ozcakar B, Uncu N, Karabay-Bayazit A, Sonmez F (2010) Turkish Society for Pediatric Nephrology Acute Kidney Injury Study Group. Etiology and outcome of acute kidney injury in children. Pediatr Nephrol 25:1453–1461PubMedCrossRef Duzova A, Bakkaloglu A, Kalyoncu M, Poyrazoglu H, Delibas A, Ozkaya O, Peru H, Alpay H, Soylemezoglu O, Gur-Guven A, Bak M, Bircan Z, Cengiz N, Akil I, Ozcakar B, Uncu N, Karabay-Bayazit A, Sonmez F (2010) Turkish Society for Pediatric Nephrology Acute Kidney Injury Study Group. Etiology and outcome of acute kidney injury in children. Pediatr Nephrol 25:1453–1461PubMedCrossRef
61.
go back to reference Basu RK, Chawla LS, Wheeler DS, Goldstein SL (2012) Renal angina: an emerging paradigm to identify children at risk for acute kidney injury. Pediatr Nephrol 27:1067–1078PubMedCrossRefPubMedCentral Basu RK, Chawla LS, Wheeler DS, Goldstein SL (2012) Renal angina: an emerging paradigm to identify children at risk for acute kidney injury. Pediatr Nephrol 27:1067–1078PubMedCrossRefPubMedCentral
62.
go back to reference Basu RK, Zappitelli M, Brunner L, Wang Y, Wong HR, Chawla LS, Wheeler DS, Goldstein SL (2013) Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int. doi:10.1038/ki.2013.349 PubMed Basu RK, Zappitelli M, Brunner L, Wang Y, Wong HR, Chawla LS, Wheeler DS, Goldstein SL (2013) Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int. doi:10.​1038/​ki.​2013.​349 PubMed
63.
go back to reference Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, Himmelfarb J, Program to Improve Care in Acute Renal Disease Study Group (2011) Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med 37:241–248PubMedCrossRefPubMedCentral Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, Himmelfarb J, Program to Improve Care in Acute Renal Disease Study Group (2011) Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med 37:241–248PubMedCrossRefPubMedCentral
64.
go back to reference Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489–1494PubMedCrossRef Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489–1494PubMedCrossRef
65.
go back to reference de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LMJ, Ansell D, Collart F, Finne P, Heaf JG, Meester JD, Wetzels JFM, Rosendaal FR, Dekker FW (2009) Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 302:1782–1789PubMedCrossRef de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LMJ, Ansell D, Collart F, Finne P, Heaf JG, Meester JD, Wetzels JFM, Rosendaal FR, Dekker FW (2009) Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 302:1782–1789PubMedCrossRef
66.
go back to reference Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I (2007) Disturbances of acquired immunity in hemodialysis patients. Semin Dial 20:440–451PubMedCrossRef Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I (2007) Disturbances of acquired immunity in hemodialysis patients. Semin Dial 20:440–451PubMedCrossRef
67.
go back to reference Wong HR, Cvijanovich N, Allen GL, Lin R, Anas N, Meyer K, Freishtat RJ, Monaco M, Odoms K, Sakthivel B, Shanley TP (2009) Genomics of Pediatric SIRS/Septic Shock Investigators. Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 37:1558–1566PubMedCrossRefPubMedCentral Wong HR, Cvijanovich N, Allen GL, Lin R, Anas N, Meyer K, Freishtat RJ, Monaco M, Odoms K, Sakthivel B, Shanley TP (2009) Genomics of Pediatric SIRS/Septic Shock Investigators. Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 37:1558–1566PubMedCrossRefPubMedCentral
68.
go back to reference Girndt M, Sester M, Sester U, Kaul H, Kohler H (2001) Molecular aspects of T- and B-cell function in uremia. Kidney Int 59(Suppl 78):S206–S211CrossRef Girndt M, Sester M, Sester U, Kaul H, Kohler H (2001) Molecular aspects of T- and B-cell function in uremia. Kidney Int 59(Suppl 78):S206–S211CrossRef
69.
go back to reference Chonchol M (2006) Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial 19:291–296PubMedCrossRef Chonchol M (2006) Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial 19:291–296PubMedCrossRef
70.
go back to reference Sardenberg C, Suassuna P, Andreoli MCC, Watanabe R, Dalboni MA, Manfredi SR, dos Santos OP, Kallas e.g., Draibe SA, Cendoroglo M (2006) Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant 21:160–165PubMedCrossRef Sardenberg C, Suassuna P, Andreoli MCC, Watanabe R, Dalboni MA, Manfredi SR, dos Santos OP, Kallas e.g., Draibe SA, Cendoroglo M (2006) Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant 21:160–165PubMedCrossRef
71.
go back to reference Carracedo J, Ramirez R, Soriano S, Alvarez de Lara MA, Rodriguez M, Martin-Malo A, Aljama P (2005) Monocytes from dialysis patients exhibit characteristics of sensescent cells: does it really mean inflammation? Contrib Nephrol 149:208–218PubMedCrossRef Carracedo J, Ramirez R, Soriano S, Alvarez de Lara MA, Rodriguez M, Martin-Malo A, Aljama P (2005) Monocytes from dialysis patients exhibit characteristics of sensescent cells: does it really mean inflammation? Contrib Nephrol 149:208–218PubMedCrossRef
72.
go back to reference Himmelfarb J (2009) Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Semin Dial 22:636–643PubMedCrossRef Himmelfarb J (2009) Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Semin Dial 22:636–643PubMedCrossRef
73.
go back to reference Daichou Y, Kurashige S, Hasimoto S, Suzuki S (1999) Characteristic cytokine products of Th1 and Th2 cells in hemodialysis patients. Nephron 83:237–245PubMedCrossRef Daichou Y, Kurashige S, Hasimoto S, Suzuki S (1999) Characteristic cytokine products of Th1 and Th2 cells in hemodialysis patients. Nephron 83:237–245PubMedCrossRef
74.
go back to reference Meier P, Dayer E, Blanc E, Wauters J-P (2002) Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol 13:204–212PubMed Meier P, Dayer E, Blanc E, Wauters J-P (2002) Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol 13:204–212PubMed
75.
go back to reference Czaja AS, Zummerman JJ, Nathens AB (2009) Readmission and late mortality after pediatric severe sepsis. Pediatrics 123:849–857PubMedCrossRef Czaja AS, Zummerman JJ, Nathens AB (2009) Readmission and late mortality after pediatric severe sepsis. Pediatrics 123:849–857PubMedCrossRef
76.
go back to reference Alvarez-Lara MA, Carracedo J, Ramirez R, Martin-Malo A, Rodriguez M, Madueño JA, Alijama P (2004) The imbalance in the ratio of Th1 and Th2 helper lymphocytes in uraemia is mediated by an increased apoptosis of Th1 subset. Nephrol Dial Transplant 19:3084–3090PubMedCrossRef Alvarez-Lara MA, Carracedo J, Ramirez R, Martin-Malo A, Rodriguez M, Madueño JA, Alijama P (2004) The imbalance in the ratio of Th1 and Th2 helper lymphocytes in uraemia is mediated by an increased apoptosis of Th1 subset. Nephrol Dial Transplant 19:3084–3090PubMedCrossRef
77.
go back to reference Labriola L, Crott R, Jadoul M (2008) Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant 23:1666–1672PubMedCrossRef Labriola L, Crott R, Jadoul M (2008) Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant 23:1666–1672PubMedCrossRef
78.
go back to reference Stefanidis CJ (2009) Prevention of catheter-related bacteremia in children on hemodialysis: time for action. Pediatr Nephrol 24:2087–2095PubMedCrossRef Stefanidis CJ (2009) Prevention of catheter-related bacteremia in children on hemodialysis: time for action. Pediatr Nephrol 24:2087–2095PubMedCrossRef
79.
go back to reference KDIGO (2012) Clinical practice guideline for acute kidney injury. Chapter 5.4: Vascular access for renal replacement therapy in AKI. Kidney Int Suppl 2:101–104 KDIGO (2012) Clinical practice guideline for acute kidney injury. Chapter 5.4: Vascular access for renal replacement therapy in AKI. Kidney Int Suppl 2:101–104
81.
go back to reference Foland JA, Fortenberry JD, Warshaw BL, Pettignano R, Merritt RK, Heard ML, Rogers K, Reid C, Tanner AJ, Easley KA (2004) Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med 32:1771–1776PubMedCrossRef Foland JA, Fortenberry JD, Warshaw BL, Pettignano R, Merritt RK, Heard ML, Rogers K, Reid C, Tanner AJ, Easley KA (2004) Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med 32:1771–1776PubMedCrossRef
82.
go back to reference Selewski DT, Cornell TT, Blatt NB, Han YY, Mottes T, Kommareddi M, Gaies MG, Annich GM, Kershaw DB, Shanley TP, Heung M (2012) Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy. Crit Care Med 40:2694–2699PubMedCrossRefPubMedCentral Selewski DT, Cornell TT, Blatt NB, Han YY, Mottes T, Kommareddi M, Gaies MG, Annich GM, Kershaw DB, Shanley TP, Heung M (2012) Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy. Crit Care Med 40:2694–2699PubMedCrossRefPubMedCentral
83.
go back to reference Goldstein SL (2009) Overview of pediatric renal replacement therapy in acute kidney injury. Semin Dial 22:180–184PubMedCrossRef Goldstein SL (2009) Overview of pediatric renal replacement therapy in acute kidney injury. Semin Dial 22:180–184PubMedCrossRef
84.
go back to reference Maclaren G, Butt W (2009) Controversies in paediatric continuous renal replacement therapy. Intensive Care Med 35:596–602PubMedCrossRef Maclaren G, Butt W (2009) Controversies in paediatric continuous renal replacement therapy. Intensive Care Med 35:596–602PubMedCrossRef
85.
go back to reference Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d’Intini V, Bellomo R (2003) Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 27:792–801PubMedCrossRef Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d’Intini V, Bellomo R (2003) Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 27:792–801PubMedCrossRef
86.
87.
go back to reference Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26–30PubMedCrossRef Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26–30PubMedCrossRef
88.
go back to reference Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY (2006) Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70:1312–1317PubMedCrossRef Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY (2006) Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70:1312–1317PubMedCrossRef
89.
go back to reference Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM (2008) Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 19:1233–1238PubMedCrossRefPubMedCentral Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM (2008) Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 19:1233–1238PubMedCrossRefPubMedCentral
90.
go back to reference VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20PubMedCrossRef VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20PubMedCrossRef
91.
go back to reference Ghani RA, Zainudin S, Ctkong N, Rahman AF, Wafa SR, Mohamad M, Manaf MR, Ismail R (2006) Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration. Nephrology (Carlton) 11:386–393CrossRef Ghani RA, Zainudin S, Ctkong N, Rahman AF, Wafa SR, Mohamad M, Manaf MR, Ismail R (2006) Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration. Nephrology (Carlton) 11:386–393CrossRef
92.
go back to reference Morgera S, Haase M, Kuss T, Vargas-Hein O, Zuckermann-Becker H, Melzer C, Krieg H, Wegner B, Bellomo R, Neumayer HH (2006) Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 34:2099–2104PubMedCrossRef Morgera S, Haase M, Kuss T, Vargas-Hein O, Zuckermann-Becker H, Melzer C, Krieg H, Wegner B, Bellomo R, Neumayer HH (2006) Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 34:2099–2104PubMedCrossRef
93.
go back to reference Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Muller JM, Baumann G, Kox WJ, Bellomo R, Neumayer HH (2004) Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 43:444–453PubMedCrossRef Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Muller JM, Baumann G, Kox WJ, Bellomo R, Neumayer HH (2004) Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 43:444–453PubMedCrossRef
94.
go back to reference De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH (1999) Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 10:846–853PubMed De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH (1999) Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 10:846–853PubMed
95.
go back to reference Haase M, Silvester W, Uchino S, Goldsmith D, Davenport P, Tipping P, Boyce N, Bellomo R (2007) A pilot study of high-adsorption hemofiltration in human septic shock. Int J Artif Organs 30:108–117PubMed Haase M, Silvester W, Uchino S, Goldsmith D, Davenport P, Tipping P, Boyce N, Bellomo R (2007) A pilot study of high-adsorption hemofiltration in human septic shock. Int J Artif Organs 30:108–117PubMed
96.
go back to reference Hirasawa H, Oda S, Nakamura M, Watanabe E, Shiga H, Matsuda K (2012) Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis. Blood Purif 34:164–170PubMedCrossRef Hirasawa H, Oda S, Nakamura M, Watanabe E, Shiga H, Matsuda K (2012) Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis. Blood Purif 34:164–170PubMedCrossRef
97.
Metadata
Title
Biology of sepsis: Its relevance to pediatric nephrology
Authors
Neal B. Blatt
Sushant Srinivasan
Theresa Mottes
Maureen M. Shanley
Thomas P. Shanley
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 12/2014
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-013-2677-3

Other articles of this Issue 12/2014

Pediatric Nephrology 12/2014 Go to the issue